
MaxWell Biosciences: A preclinical stage biotech firm optimizing cognitive health.
MaxWell Biosciences, founded with a mission to optimize cognitive health and extend healthspan, is a preclinical stage biotechnology company. Utilizing artificial intelligence to analyze proteomics, the company focuses on developing a synthetic immune system aimed at restoring immunity, repairing tissues, and combating infections that drive age-related decline. Their innovative drug platform targets cognitive performance and overall health improvement.
Notable figures affiliated with MaxWell Biosciences include experts in biotechnology and artificial intelligence, contributing to the company's pioneering research. The company has attracted significant interest from investors due to its cutting-edge approach to healthspan extension. Key achievements include advancements in their synthetic immune system technology, which holds promise for addressing major causes of age-related health issues. MaxWell Biosciences is poised to make a substantial impact on the future of cognitive health and longevity.

Regenerative Bio
regen-bio.us

Think Bioscience

Retro Biosciences
retro.bio

AI Proteins
aiproteinstx.com

Parallel Bio
parallel.bio

Juvenescence
juvlabs.com

Synlife
synlifebio.com

Metanovas Biotech
metanovas.com

Manifold Bio
manifold.bio

DeepBiome Therapeutics

Twist Bioscience

Medium Biosciences
medium.bio

Aibios
aibios.com

AgeX Therapeutics

TenSixty Biosciences
tensixty.bio
Companies similar to Maxwell Biosciences include Regenerative Bio, Think Bioscience, Retro Biosciences and AI Proteins.
Maxwell Biosciences was founded in 2016.
Maxwell Biosciences' headquarters is located in Austin, TX, US.
Maxwell Biosciences' most recent funding round was for $10.8M (USD) in March 2022.
As of Mar 10, 2022, Maxwell Biosciences has raised a total of $10.8M (USD).
Maxwell Biosciences has 37 employees as of Feb 5, 2024.